Status of IKZF1 Deletions in Diagnose and Relapsed Pediatric B-ALL Patients
Biochemical Genetics · 2026
DOI: 10.1007/s10528-024-11018-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Genetics, 2026. Verfasst von Yücel Erbilgin und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Topkapı mh, Gureba Hastanesi Cd. No:69, 34093, Fatih, Is…. Hauptthemen laut MEDLINE: Ikaros Transcription Factor, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Gene Deletion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Research Fund of Istanbul University, The Scientific and Technological Research Council of Türkiye.
Abstract (Originalsprache)
IKZF1 deletions (ΔIKZF1) are common in precursor B-cell acute lymphoblastic leukemia (B-ALL) and are assumed to have a prognostic impact. We aimed to determine the prognostic implications of ΔIKZF1 and CRLF2 overexpression in pediatric B-ALL. Furthermore, we sought to compare the multiplex polymerase chain reaction (PCR) assay with standard multiplex ligand-dependent probe amplification (MLPA) methods to ascertain IKZF1 status in a clinical context. Seventy-nine diagnoses and 43 relapse B-ALL samples were evaluated for deletions of IKZF1 Δ2-7, Δ4-7, and Δ4-8 by conventional PCR and then sequenced by targeted sequencing. Subsequently, MLPA analysis was performed for ΔIKZF1 detection, and CRLF2 expression was evaluated in 42 diagnose time B-ALL patients by QRT-PCR. ΔIKZF1 was detected in 10 out of 79 diagnose samples (12.66%) and eight of the 43 first relapsed materials (18.60%). Our results revealed no association between survival outcomes with ΔIKZF1 or CRLF2 overexpression status in pediatric B-ALL patients. However, we found ΔIKZF1 was more frequent among relapsed samples, and the deletions showed consistency between diagnose-first/second relapse pairs of samples. These results suggest that ΔIKZF1 may contribute to the development of treatment failure in B-ALL. Furthermore, we demonstrated methodological adjustments in conventional PCR and MLPA for selected alterations in ΔIKZF1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Topkapı mh, Gureba Hastanesi Cd. No:69, 34093, Fatih, Istanbul, Turkey. yucel.erbilgin@istanbul.edu.tr.
- Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Topkapı mh, Gureba Hastanesi Cd. No:69, 34093, Fatih, Istanbul, Turkey.
- Department of Internal Medicine, Department of Medical Genetics, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
- Institute of Health Sciences, Istanbul University, Istanbul, Turkey.
- Pediatric Hematology Oncology Department, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
- Division of Pediatric Hematology Oncology, Department of Pediatrics, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Förderung
- Research Fund of Istanbul University
- The Scientific and Technological Research Council of Türkiye
Zitieren
APA
Erbilgin, Y., Firtina, S., Kirat, E., Khodzhaev, K., Karakas, Z., Ünüvar, A., Ocak, S., Celkan, T. T., Zengin, E., Aylan Gelen, S., Yildirmak, Z. Y., Toluk, O., Hatirnaz Ng, O., Ozbek, U., & Sayitoglu, M. (2026). Status of IKZF1 Deletions in Diagnose and Relapsed Pediatric B-ALL Patients. Biochemical Genetics. https://doi.org/10.1007/s10528-024-11018-7
Vancouver
Erbilgin Y, Firtina S, Kirat E, Khodzhaev K, Karakas Z, Ünüvar A, et al. Status of IKZF1 Deletions in Diagnose and Relapsed Pediatric B-ALL Patients. Biochemical Genetics. 2026. doi:10.1007/s10528-024-11018-7
BibTeX
@article{Erbilgin2026,
author = {Erbilgin, Yücel and Firtina, Sinem and Kirat, Elif and Khodzhaev, Khusan and Karakas, Zeynep and Ünüvar, Ayşegül and Ocak, Süheyla and Celkan, Tülin Tiraje and Zengin, Emine and Aylan Gelen, Sema and Yildirmak, Zeynep Yildiz and Toluk, Ozlem and Hatirnaz Ng, Ozden and Ozbek, Ugur and Sayitoglu, Müge},
title = {Status of IKZF1 Deletions in Diagnose and Relapsed Pediatric B-ALL Patients},
journal = {Biochemical Genetics},
year = {2026},
doi = {10.1007/s10528-024-11018-7}
}
EUVIMED